SCVAX | VISVX | SCVAX / VISVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 27 years | - |
Gain YTD | 14.623 | 15.433 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 699M | 57.6B | 1% |
Annual Yield % from dividends | 0.73 | 1.90 | 38% |
Returns for 1 year | 29.78 | 28.71 | 104% |
Returns for 3 years | 2.00 | 13.23 | 15% |
Returns for 5 years | 53.70 | 57.32 | 94% |
Returns for 10 years | 106.63 | 108.21 | 99% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PRUZX | 16.89 | 0.23 | +1.38% |
PGIM Jennison Utility Z | |||
CSHNX | 11.70 | 0.11 | +0.95% |
NYLI Cushing® MLP Premier Investor Class | |||
EVDAX | 20.46 | 0.06 | +0.29% |
Camelot Event Driven A | |||
PACLX | 37.54 | -0.43 | -1.13% |
T. Rowe Price Capital Appreciation Adv | |||
BGPKX | 12.53 | -0.18 | -1.42% |
Baillie Gifford Developed EAFE All Cap K |